These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 7601145)
1. Biosynthesis and biological activities of lantibiotics with unique post-translational modifications. Sahl HG; Jack RW; Bierbaum G Eur J Biochem; 1995 Jun; 230(3):827-53. PubMed ID: 7601145 [TBL] [Abstract][Full Text] [Related]
2. Unique peptide modifications involved in the biosynthesis of lantibiotics. Jack RW; Sahl HG Trends Biotechnol; 1995 Jul; 13(7):269-78. PubMed ID: 7646850 [TBL] [Abstract][Full Text] [Related]
3. Multiple activities in lantibiotics--models for the design of novel antibiotics? Pag U; Sahl HG Curr Pharm Des; 2002; 8(9):815-33. PubMed ID: 11945173 [TBL] [Abstract][Full Text] [Related]
4. The biosynthesis of the lantibiotics epidermin, gallidermin, Pep5 and epilancin K7. Bierbaum G; Götz F; Peschel A; Kupke T; van de Kamp M; Sahl HG Antonie Van Leeuwenhoek; 1996 Feb; 69(2):119-127. PubMed ID: 8775972 [TBL] [Abstract][Full Text] [Related]
5. Comparison of lantibiotic gene clusters and encoded proteins. Siezen RJ; Kuipers OP; de Vos WM Antonie Van Leeuwenhoek; 1996 Feb; 69(2):171-84. PubMed ID: 8775977 [TBL] [Abstract][Full Text] [Related]
11. Lantibiotics: insight and foresight for new paradigm. Nagao J; Asaduzzaman SM; Aso Y; Okuda K; Nakayama J; Sonomoto K J Biosci Bioeng; 2006 Sep; 102(3):139-49. PubMed ID: 17046525 [TBL] [Abstract][Full Text] [Related]
12. New developments in lantibiotic biosynthesis and mode of action. Patton GC; van der Donk WA Curr Opin Microbiol; 2005 Oct; 8(5):543-51. PubMed ID: 16118063 [TBL] [Abstract][Full Text] [Related]
13. Lantibiotics: structure, biosynthesis and mode of action. McAuliffe O; Ross RP; Hill C FEMS Microbiol Rev; 2001 May; 25(3):285-308. PubMed ID: 11348686 [TBL] [Abstract][Full Text] [Related]
14. Nucleotide sequence of the lantibiotic Pep5 biosynthetic gene cluster and functional analysis of PepP and PepC. Evidence for a role of PepC in thioether formation. Meyer C; Bierbaum G; Heidrich C; Reis M; Süling J; Iglesias-Wind MI; Kempter C; Molitor E; Sahl HG Eur J Biochem; 1995 Sep; 232(2):478-89. PubMed ID: 7556197 [TBL] [Abstract][Full Text] [Related]
15. Post-translational modifications of lantibiotics. Kupke T; Götz F Antonie Van Leeuwenhoek; 1996 Feb; 69(2):139-50. PubMed ID: 8775974 [TBL] [Abstract][Full Text] [Related]
16. Bacterial lantibiotics: strategies to improve therapeutic potential. Cotter PD; Hill C; Ross RP Curr Protein Pept Sci; 2005 Feb; 6(1):61-75. PubMed ID: 15638769 [TBL] [Abstract][Full Text] [Related]
17. Novel lantibiotics and their pre-peptides. Nes IF; Tagg JR Antonie Van Leeuwenhoek; 1996 Feb; 69(2):89-97. PubMed ID: 8775969 [TBL] [Abstract][Full Text] [Related]
18. Genome mining and genetic analysis of cypemycin biosynthesis reveal an unusual class of posttranslationally modified peptides. Claesen J; Bibb M Proc Natl Acad Sci U S A; 2010 Sep; 107(37):16297-302. PubMed ID: 20805503 [TBL] [Abstract][Full Text] [Related]
19. Engineering of a novel thioether bridge and role of modified residues in the lantibiotic Pep5. Bierbaum G; Szekat C; Josten M; Heidrich C; Kempter C; Jung G; Sahl HG Appl Environ Microbiol; 1996 Feb; 62(2):385-92. PubMed ID: 8593044 [TBL] [Abstract][Full Text] [Related]